ADDvise receives order from Consto AS worth 2,9 MNOK

14-02-2017   Regulatory press release

ADDvise Group AB’s (publ) subsidiary LabRum AB has signed an agreement with Consto AS for a delivery of pass through cupboards to PET center in Tromsø, Norway.

PET (Positron Emissions Tomografi) is a technique creating images used for studying metabolic diseases. The method consists of injecting a radioactively marked substance in the body, the radioactivity can then be traced to detect different diseases. The pass through cupboards, with HEPA filters and lead glass, will be connected to the ventilation.

The order is worth approximately 2,9 MNOK and will be delivered during the second and third quarters of 2017.

-       Today’s order is once again a proof for our continued growth and presence on the Nordic market, says Rikard Akhtarzand CEO for ADDvise Group AB concerning the new agreement.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se 


Important information:
 

This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on February 14th, 2017 at 11:45 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.